Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal

Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid adverse events. However, this can result in severe disease reactivation occasionally presenting with tumefactive...

Full description

Bibliographic Details
Main Authors: Valeria Koska, Moritz Förster, Katja Brouzou, Ercan Arat, Philipp Albrecht, Orhan Aktas, Patrick Küry, Sven G. Meuth, David Kremer
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
rebound
tumefactive
lymphopenia
neuropsychiatric
fingolimod
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.785180/full

Similar Items

Similar Items